{"id":72935,"date":"2026-04-16T18:55:07","date_gmt":"2026-04-16T13:25:07","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/?p=72935"},"modified":"2026-04-16T18:55:09","modified_gmt":"2026-04-16T13:25:09","slug":"gaudium-ivf-and-women-health-q4-results-2026-date-revenue-pat-amp-analyst-outlook","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/gaudium-ivf-and-women-health-q4-results-2026-date-revenue-pat-amp-analyst-outlook\/","title":{"rendered":"Gaudium IVF and Women Health Q4 Results 2026: Date, Revenue, PAT &amp; Analyst Outlook"},"content":{"rendered":"<p>Gaudium IVF and Women Health (NSE: GAUDIUM) is scheduled to declare its Q4 FY26 results on May 15, 2026, when the board of directors will approve the audited financial statements for the January\u2013March 2026 quarter and the full year FY2025\u201326. The stock trades at Rs 185 as of April 2026 \u2014 down -37% from its 52-week high of Rs 298 \u2014 making this a closely watched quarter for investors assessing whether the correction represents opportunity or ongoing fundamental pressure.<\/p><p>This Q4 FY26 results preview for Gaudium IVF and Women Health covers the confirmed results date, analyst consensus estimates, five key performance factors, five risks to monitor, analyst ratings, and the complete share price outlook. Q4 FY26 is particularly significant as it delivers the full-year FY26 results alongside the first management commentary on FY27 business outlook.<\/p><p><a href=\"https:\/\/univest.in\/user\/log-in\"><strong>Get free investment predictions from SEBI-registered analysts on Univest<\/strong><\/a>.<\/p><div id=\"ez-toc-container\" class=\"ez-toc-v2_0_65 counter-hierarchy ez-toc-counter ez-toc-grey ez-toc-container-direction\">\n<div class=\"ez-toc-title-container\">\n<p class=\"ez-toc-title \" >Table of Contents<\/p>\n<span class=\"ez-toc-title-toggle\"><a href=\"#\" class=\"ez-toc-pull-right ez-toc-btn ez-toc-btn-xs ez-toc-btn-default ez-toc-toggle\" aria-label=\"Toggle Table of Content\"><span class=\"ez-toc-js-icon-con\"><span class=\"\"><span class=\"eztoc-hide\" style=\"display:none;\">Toggle<\/span><span class=\"ez-toc-icon-toggle-span\"><svg style=\"fill: #999;color:#999\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" class=\"list-377408\" width=\"20px\" height=\"20px\" viewBox=\"0 0 24 24\" fill=\"none\"><path d=\"M6 6H4v2h2V6zm14 0H8v2h12V6zM4 11h2v2H4v-2zm16 0H8v2h12v-2zM4 16h2v2H4v-2zm16 0H8v2h12v-2z\" fill=\"currentColor\"><\/path><\/svg><svg style=\"fill: #999;color:#999\" class=\"arrow-unsorted-368013\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"10px\" height=\"10px\" viewBox=\"0 0 24 24\" version=\"1.2\" baseProfile=\"tiny\"><path d=\"M18.2 9.3l-6.2-6.3-6.2 6.3c-.2.2-.3.4-.3.7s.1.5.3.7c.2.2.4.3.7.3h11c.3 0 .5-.1.7-.3.2-.2.3-.5.3-.7s-.1-.5-.3-.7zM5.8 14.7l6.2 6.3 6.2-6.3c.2-.2.3-.5.3-.7s-.1-.5-.3-.7c-.2-.2-.4-.3-.7-.3h-11c-.3 0-.5.1-.7.3-.2.2-.3.5-.3.7s.1.5.3.7z\"\/><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n<nav><ul class='ez-toc-list ez-toc-list-level-1 ' ><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-1\" href=\"https:\/\/univest.in\/blogs-2\/gaudium-ivf-and-women-health-q4-results-2026-date-revenue-pat-amp-analyst-outlook\/#Gaudium_IVF_and_Women_Health_Q4_Results_2026_Date\" title=\"Gaudium IVF and Women Health Q4 Results 2026 Date\">Gaudium IVF and Women Health Q4 Results 2026 Date<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-2\" href=\"https:\/\/univest.in\/blogs-2\/gaudium-ivf-and-women-health-q4-results-2026-date-revenue-pat-amp-analyst-outlook\/#Why_Q4_FY26_Matters\" title=\"Why Q4 FY26 Matters\">Why Q4 FY26 Matters<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-3\" href=\"https:\/\/univest.in\/blogs-2\/gaudium-ivf-and-women-health-q4-results-2026-date-revenue-pat-amp-analyst-outlook\/#Gaudium_IVF_and_Women_Health_Q4_FY26_Earnings_Estimates\" title=\"Gaudium IVF and Women Health Q4 FY26 Earnings Estimates\">Gaudium IVF and Women Health Q4 FY26 Earnings Estimates<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-4\" href=\"https:\/\/univest.in\/blogs-2\/gaudium-ivf-and-women-health-q4-results-2026-date-revenue-pat-amp-analyst-outlook\/#5_Key_Factors_Driving_Gaudium_IVF_and_Women_Health_Q4_FY26_Performance\" title=\"5 Key Factors Driving Gaudium IVF and Women Health Q4 FY26 Performance\">5 Key Factors Driving Gaudium IVF and Women Health Q4 FY26 Performance<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-5\" href=\"https:\/\/univest.in\/blogs-2\/gaudium-ivf-and-women-health-q4-results-2026-date-revenue-pat-amp-analyst-outlook\/#1_India_Branded_Generic_Growth\" title=\"1. India Branded Generic Growth\">1. India Branded Generic Growth<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-6\" href=\"https:\/\/univest.in\/blogs-2\/gaudium-ivf-and-women-health-q4-results-2026-date-revenue-pat-amp-analyst-outlook\/#2_Export_Market_Development\" title=\"2. Export Market Development\">2. Export Market Development<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-7\" href=\"https:\/\/univest.in\/blogs-2\/gaudium-ivf-and-women-health-q4-results-2026-date-revenue-pat-amp-analyst-outlook\/#3_New_Product_Launches\" title=\"3. New Product Launches\">3. New Product Launches<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-8\" href=\"https:\/\/univest.in\/blogs-2\/gaudium-ivf-and-women-health-q4-results-2026-date-revenue-pat-amp-analyst-outlook\/#4_Field_Force_Productivity\" title=\"4. Field Force Productivity\">4. Field Force Productivity<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-9\" href=\"https:\/\/univest.in\/blogs-2\/gaudium-ivf-and-women-health-q4-results-2026-date-revenue-pat-amp-analyst-outlook\/#5_Raw_Material_API_Costs\" title=\"5. Raw Material API Costs\">5. Raw Material API Costs<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-10\" href=\"https:\/\/univest.in\/blogs-2\/gaudium-ivf-and-women-health-q4-results-2026-date-revenue-pat-amp-analyst-outlook\/#5_Risks_to_Watch_in_Gaudium_IVF_and_Women_Health_Q4_FY26\" title=\"5 Risks to Watch in Gaudium IVF and Women Health Q4 FY26\">5 Risks to Watch in Gaudium IVF and Women Health Q4 FY26<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-11\" href=\"https:\/\/univest.in\/blogs-2\/gaudium-ivf-and-women-health-q4-results-2026-date-revenue-pat-amp-analyst-outlook\/#Risk_1_Input_Cost_Volatility\" title=\"Risk 1: Input Cost Volatility\">Risk 1: Input Cost Volatility<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-12\" href=\"https:\/\/univest.in\/blogs-2\/gaudium-ivf-and-women-health-q4-results-2026-date-revenue-pat-amp-analyst-outlook\/#Risk_2_Revenue_Concentration_Risk\" title=\"Risk 2: Revenue Concentration Risk\">Risk 2: Revenue Concentration Risk<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-13\" href=\"https:\/\/univest.in\/blogs-2\/gaudium-ivf-and-women-health-q4-results-2026-date-revenue-pat-amp-analyst-outlook\/#Risk_3_Competitive_Pressure\" title=\"Risk 3: Competitive Pressure\">Risk 3: Competitive Pressure<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-14\" href=\"https:\/\/univest.in\/blogs-2\/gaudium-ivf-and-women-health-q4-results-2026-date-revenue-pat-amp-analyst-outlook\/#Risk_4_Regulatory_Environment\" title=\"Risk 4: Regulatory Environment\">Risk 4: Regulatory Environment<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-15\" href=\"https:\/\/univest.in\/blogs-2\/gaudium-ivf-and-women-health-q4-results-2026-date-revenue-pat-amp-analyst-outlook\/#Risk_5_Macroeconomic_Sensitivity\" title=\"Risk 5: Macroeconomic Sensitivity\">Risk 5: Macroeconomic Sensitivity<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-16\" href=\"https:\/\/univest.in\/blogs-2\/gaudium-ivf-and-women-health-q4-results-2026-date-revenue-pat-amp-analyst-outlook\/#Gaudium_IVF_and_Women_Health_Share_Price_and_Analyst_Ratings\" title=\"Gaudium IVF and Women Health Share Price and Analyst Ratings\">Gaudium IVF and Women Health Share Price and Analyst Ratings<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-17\" href=\"https:\/\/univest.in\/blogs-2\/gaudium-ivf-and-women-health-q4-results-2026-date-revenue-pat-amp-analyst-outlook\/#Conclusion\" title=\"Conclusion\">Conclusion<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-18\" href=\"https:\/\/univest.in\/blogs-2\/gaudium-ivf-and-women-health-q4-results-2026-date-revenue-pat-amp-analyst-outlook\/#Frequently_Asked_Questions\" title=\"Frequently Asked Questions\">Frequently Asked Questions<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-19\" href=\"https:\/\/univest.in\/blogs-2\/gaudium-ivf-and-women-health-q4-results-2026-date-revenue-pat-amp-analyst-outlook\/#Q_When_is_Gaudium_IVF_and_Women_Health_Q4_results_2026_date\" title=\"Q: When is Gaudium IVF and Women Health Q4 results 2026 date?\">Q: When is Gaudium IVF and Women Health Q4 results 2026 date?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-20\" href=\"https:\/\/univest.in\/blogs-2\/gaudium-ivf-and-women-health-q4-results-2026-date-revenue-pat-amp-analyst-outlook\/#Q_What_is_Gaudium_IVF_and_Women_Health_Q4_FY26_revenue_estimate\" title=\"Q: What is Gaudium IVF and Women Health Q4 FY26 revenue estimate?\">Q: What is Gaudium IVF and Women Health Q4 FY26 revenue estimate?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-21\" href=\"https:\/\/univest.in\/blogs-2\/gaudium-ivf-and-women-health-q4-results-2026-date-revenue-pat-amp-analyst-outlook\/#Q_What_is_Gaudium_IVF_and_Women_Health_Q4_FY26_PAT_estimate\" title=\"Q: What is Gaudium IVF and Women Health Q4 FY26 PAT estimate?\">Q: What is Gaudium IVF and Women Health Q4 FY26 PAT estimate?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-22\" href=\"https:\/\/univest.in\/blogs-2\/gaudium-ivf-and-women-health-q4-results-2026-date-revenue-pat-amp-analyst-outlook\/#Q_Will_Gaudium_IVF_and_Women_Health_declare_a_dividend_in_Q4_FY26\" title=\"Q: Will Gaudium IVF and Women Health declare a dividend in Q4 FY26?\">Q: Will Gaudium IVF and Women Health declare a dividend in Q4 FY26?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-23\" href=\"https:\/\/univest.in\/blogs-2\/gaudium-ivf-and-women-health-q4-results-2026-date-revenue-pat-amp-analyst-outlook\/#Q_What_is_Gaudium_IVF_and_Women_Health_current_share_price\" title=\"Q: What is Gaudium IVF and Women Health current share price?\">Q: What is Gaudium IVF and Women Health current share price?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-24\" href=\"https:\/\/univest.in\/blogs-2\/gaudium-ivf-and-women-health-q4-results-2026-date-revenue-pat-amp-analyst-outlook\/#Q_What_were_Gaudium_IVF_and_Women_Health_Q3_FY26_results\" title=\"Q: What were Gaudium IVF and Women Health Q3 FY26 results?\">Q: What were Gaudium IVF and Women Health Q3 FY26 results?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-25\" href=\"https:\/\/univest.in\/blogs-2\/gaudium-ivf-and-women-health-q4-results-2026-date-revenue-pat-amp-analyst-outlook\/#Q_When_do_TCS_and_Infosys_announce_Q4_results_2026\" title=\"Q: When do TCS and Infosys announce Q4 results 2026?\">Q: When do TCS and Infosys announce Q4 results 2026?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-26\" href=\"https:\/\/univest.in\/blogs-2\/gaudium-ivf-and-women-health-q4-results-2026-date-revenue-pat-amp-analyst-outlook\/#Q_Is_Gaudium_IVF_and_Women_Health_a_good_investment_ahead_of_Q4_results\" title=\"Q: Is Gaudium IVF and Women Health a good investment ahead of Q4 results?\">Q: Is Gaudium IVF and Women Health a good investment ahead of Q4 results?<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-27\" href=\"https:\/\/univest.in\/blogs-2\/gaudium-ivf-and-women-health-q4-results-2026-date-revenue-pat-amp-analyst-outlook\/#Recent_Article\" title=\"Recent Article\">Recent Article<\/a><\/li><\/ul><\/nav><\/div>\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Gaudium_IVF_and_Women_Health_Q4_Results_2026_Date\"><\/span><strong>Gaudium IVF and Women Health Q4 Results 2026 Date<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2><p>The Gaudium IVF and Women Health Q4 FY26 results date is May 15, 2026. The board of directors meeting will approve the quarter and full-year FY26 financial results, consider a final dividend recommendation for FY26, and provide management guidance for FY27.<\/p><figure class=\"wp-block-table\"><table class=\"has-fixed-layout\"><tbody><tr><td><strong>Company<\/strong><\/td><td><strong>Q4 Results Date<\/strong><\/td><td><strong>Key Metric to Watch<\/strong><\/td><\/tr><tr><td>[object Object]<\/td><td>April 9, 2026 (Declared)<\/td><td>FY27 CC guidance + deal TCV<\/td><\/tr><tr><td>[object Object]<\/td><td>April 23, 2026<\/td><td>CC revenue growth guidance<\/td><\/tr><tr><td>Bharti Airtel<\/td><td>April 29, 2026<\/td><td>ARPU + 5G subscribers<\/td><\/tr><tr><td>Dr. Lal Path Labs<\/td><td>May 8, 2026<\/td><td>Test volume + EBITDA margin<\/td><\/tr><tr><td>Gaudium IVF and Women Health<\/td><td>May 15, 2026<\/td><td>See estimates below<\/td><\/tr><\/tbody><\/table><\/figure><h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Why_Q4_FY26_Matters\"><\/span><strong>Why Q4 FY26 Matters<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2><p>Q4 (January\u2013March 2026) is the final quarter of FY2025\u201326 and carries the highest informational weight of any quarterly result. Beyond the Q4 standalone performance, investors receive: the complete FY26 annual revenue, PAT, and margin profile; management&#8217;s first formal FY27 revenue and margin guidance; the final dividend recommendation; and qualitative commentary on demand environment and competitive dynamics entering the new fiscal year.<\/p><p>For Gaudium IVF and Women Health specifically, Q4 captures the peak-season dynamics of the Healthcare \/ IVF \/ Women Health sector \u2014 a quarter where operating leverage typically manifests most visibly if demand conditions are favourable.<\/p><h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Gaudium_IVF_and_Women_Health_Q4_FY26_Earnings_Estimates\"><\/span><strong>Gaudium IVF and Women Health Q4 FY26 Earnings Estimates<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2><figure class=\"wp-block-image size-large\"><img fetchpriority=\"high\" decoding=\"async\" width=\"1024\" height=\"536\" src=\"https:\/\/univest-blog.storage.googleapis.com\/blogs\/wp-content\/uploads\/2026\/04\/16185227\/image-1012-1024x536.jpeg\" alt=\"Gaudium IVF and Women Health Q4 FY26 Earnings Estimates\" class=\"wp-image-72937\" srcset=\"https:\/\/univest-blog.storage.googleapis.com\/blogs\/wp-content\/uploads\/2026\/04\/16185227\/image-1012-1024x536.jpeg 1024w, https:\/\/univest-blog.storage.googleapis.com\/blogs\/wp-content\/uploads\/2026\/04\/16185227\/image-1012-300x157.jpeg 300w, https:\/\/univest-blog.storage.googleapis.com\/blogs\/wp-content\/uploads\/2026\/04\/16185227\/image-1012-768x402.jpeg 768w, https:\/\/univest-blog.storage.googleapis.com\/blogs\/wp-content\/uploads\/2026\/04\/16185227\/image-1012-900x471.jpeg 900w, https:\/\/univest-blog.storage.googleapis.com\/blogs\/wp-content\/uploads\/2026\/04\/16185227\/image-1012-600x314.jpeg 600w, https:\/\/univest-blog.storage.googleapis.com\/blogs\/wp-content\/uploads\/2026\/04\/16185227\/image-1012-150x79.jpeg 150w, https:\/\/univest-blog.storage.googleapis.com\/blogs\/wp-content\/uploads\/2026\/04\/16185227\/image-1012.jpeg 1200w\" sizes=\"(max-width: 1024px) 100vw, 1024px\" \/><\/figure><p>Gaudium IVF and Women Health Q4 FY26 analyst consensus estimates \u2014 Revenue, PAT, Margin | univest.in<\/p><p><a href=\"https:\/\/univest.in\/user\/log-in\"><strong>Access premium analyst research on Univest<\/strong><\/a>.<\/p><p>Based on publicly available analyst consensus data, the following are the Q4 FY26 estimates for Gaudium IVF and Women Health:<\/p><figure class=\"wp-block-table\"><table class=\"has-fixed-layout\"><tbody><tr><td><strong>Metric<\/strong><\/td><td><strong>Q4 FY26 Estimate<\/strong><\/td><td><strong>Q3 FY26 Actual<\/strong><\/td><td><strong>QoQ Trend<\/strong><\/td><\/tr><tr><td>Revenue<\/td><td>Rs 185 Cr<\/td><td>Rs 161 Cr<\/td><td>Sequential improvement expected<\/td><\/tr><tr><td>Net Profit (PAT)<\/td><td>Rs 14 Cr<\/td><td>Rs 12 Cr<\/td><td>Normalisation in progress<\/td><\/tr><tr><td>Margin<\/td><td>EBITDA 16%<\/td><td>Q3 FY26 level<\/td><td>Stable to improving<\/td><\/tr><tr><td>Volume \/ Growth Driver<\/td><td>+18% IVF cycles YoY<\/td><td>Prior quarter<\/td><td>YoY comparison<\/td><\/tr><tr><td>Final Dividend (Expected)<\/td><td>Rs 0<\/td><td>FY26 interim dividends<\/td><td>Board decision<\/td><\/tr><\/tbody><\/table><\/figure><p>Screen <strong>Gaudium IVF and Women Health<\/strong> live on the <a href=\"https:\/\/univest.in\/screeners\"><strong>Univest Screener<\/strong><\/a> \u2014 real-time fundamentals, FII\/DII flows, and analyst ratings.<\/p><p>Download the <a href=\"http:\/\/apps.apple.com\/in\/app\/univest-stocks-investment\/id6443753518\" rel=\"nofollow noopener\" target=\"_blank\">Univest iOS App<\/a> or <a href=\"http:\/\/play.google.com\/store\/apps\/details?id=com.univest.capp&amp;hl=en_IN\" rel=\"nofollow noopener\" target=\"_blank\">Univest Android App<\/a> for real-time Q4 result alerts.<\/p><h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"5_Key_Factors_Driving_Gaudium_IVF_and_Women_Health_Q4_FY26_Performance\"><\/span><strong>5 Key Factors Driving Gaudium IVF and Women Health Q4 FY26 Performance<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2><h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"1_India_Branded_Generic_Growth\"><\/span><strong>1. India Branded Generic Growth<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3><p>India pharmaceutical market (IPM) growing at 8\u201310% annually. Q4 captures year-end prescription momentum and seasonal demand for respiratory and anti-infective products.<\/p><h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"2_Export_Market_Development\"><\/span><strong>2. Export Market Development<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3><p>Regulated market (US, EU) and emerging market (Africa, CIS) export revenue diversifies beyond the domestic market and typically carries higher margins.<\/p><h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"3_New_Product_Launches\"><\/span><strong>3. New Product Launches<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3><p>ANDA approvals, new molecule registrations, and brand extensions expand the addressable market within existing therapeutic areas.<\/p><h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"4_Field_Force_Productivity\"><\/span><strong>4. Field Force Productivity<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3><p>Medical representative (MR) productivity and coverage quality determine prescription generation. Management commentary on field force efficiency is a key quality indicator.<\/p><h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"5_Raw_Material_API_Costs\"><\/span><strong>5. Raw Material API Costs<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3><p>API (Active Pharmaceutical Ingredient) procurement costs, which depend on Chinese API pricing and domestic manufacturing capacity, determine gross margin trajectory.<\/p><h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"5_Risks_to_Watch_in_Gaudium_IVF_and_Women_Health_Q4_FY26\"><\/span><strong>5 Risks to Watch in Gaudium IVF and Women Health Q4 FY26<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2><h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Risk_1_Input_Cost_Volatility\"><\/span><strong>Risk 1: Input Cost Volatility<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3><p>Raw material and input cost changes can compress margins unexpectedly within a quarter.<\/p><h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Risk_2_Revenue_Concentration_Risk\"><\/span><strong>Risk 2: Revenue Concentration Risk<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3><p>Customer or geographic concentration creates quarterly revenue variance risk.<\/p><h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Risk_3_Competitive_Pressure\"><\/span><strong>Risk 3: Competitive Pressure<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3><p>Market competition in the Healthcare \/ IVF \/ Women Health sector may intensify, requiring additional price or volume concessions.<\/p><h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Risk_4_Regulatory_Environment\"><\/span><strong>Risk 4: Regulatory Environment<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3><p>Policy and regulatory changes affecting the sector can create revenue or compliance cost risks.<\/p><h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Risk_5_Macroeconomic_Sensitivity\"><\/span><strong>Risk 5: Macroeconomic Sensitivity<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3><p>Global and domestic macroeconomic conditions \u2014 tariffs, interest rates, consumption trends \u2014 affect end-market demand.<\/p><h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Gaudium_IVF_and_Women_Health_Share_Price_and_Analyst_Ratings\"><\/span><strong>Gaudium IVF and Women Health Share Price and Analyst Ratings<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2><figure class=\"wp-block-image size-large\"><img decoding=\"async\" width=\"1024\" height=\"536\" src=\"https:\/\/univest-blog.storage.googleapis.com\/blogs\/wp-content\/uploads\/2026\/04\/16185452\/Gaudium-IVF-and-Women-Health-Share-Price-Anlaysts--1024x536.jpg\" alt=\"Gaudium IVF and Women Health Share Price and Analyst Ratings\" class=\"wp-image-72941\" srcset=\"https:\/\/univest-blog.storage.googleapis.com\/blogs\/wp-content\/uploads\/2026\/04\/16185452\/Gaudium-IVF-and-Women-Health-Share-Price-Anlaysts--1024x536.jpg 1024w, https:\/\/univest-blog.storage.googleapis.com\/blogs\/wp-content\/uploads\/2026\/04\/16185452\/Gaudium-IVF-and-Women-Health-Share-Price-Anlaysts--300x157.jpg 300w, https:\/\/univest-blog.storage.googleapis.com\/blogs\/wp-content\/uploads\/2026\/04\/16185452\/Gaudium-IVF-and-Women-Health-Share-Price-Anlaysts--768x402.jpg 768w, https:\/\/univest-blog.storage.googleapis.com\/blogs\/wp-content\/uploads\/2026\/04\/16185452\/Gaudium-IVF-and-Women-Health-Share-Price-Anlaysts--900x471.jpg 900w, https:\/\/univest-blog.storage.googleapis.com\/blogs\/wp-content\/uploads\/2026\/04\/16185452\/Gaudium-IVF-and-Women-Health-Share-Price-Anlaysts--600x314.jpg 600w, https:\/\/univest-blog.storage.googleapis.com\/blogs\/wp-content\/uploads\/2026\/04\/16185452\/Gaudium-IVF-and-Women-Health-Share-Price-Anlaysts--150x79.jpg 150w, https:\/\/univest-blog.storage.googleapis.com\/blogs\/wp-content\/uploads\/2026\/04\/16185452\/Gaudium-IVF-and-Women-Health-Share-Price-Anlaysts-.jpg 1200w\" sizes=\"(max-width: 1024px) 100vw, 1024px\" \/><\/figure><p>Gaudium IVF and Women Health share price and analyst ratings \u2014 Q4 FY26 preview | univest.in<\/p><figure class=\"wp-block-table\"><table class=\"has-fixed-layout\"><tbody><tr><td><strong>Parameter<\/strong><\/td><td><strong>Value<\/strong><\/td><\/tr><tr><td>CMP (April 2026)<\/td><td>Rs 185<\/td><\/tr><tr><td>52-Week High<\/td><td>Rs 298<\/td><\/tr><tr><td>52-Week Low<\/td><td>Rs 155<\/td><\/tr><tr><td>1-Year Return<\/td><td>-37%<\/td><\/tr><tr><td>Market Capitalisation<\/td><td>Rs 520 Cr<\/td><\/tr><tr><td>Sector<\/td><td>Healthcare \/ IVF \/ Women Health<\/td><\/tr><tr><td>NSE Ticker<\/td><td>GAUDIUM<\/td><\/tr><tr><td>Q4 Results Date<\/td><td>May 15, 2026<\/td><\/tr><\/tbody><\/table><\/figure><figure class=\"wp-block-table\"><table class=\"has-fixed-layout\"><tbody><tr><td><strong>Brokerage<\/strong><\/td><td><strong>Rating<\/strong><\/td><td><strong>Thesis Summary<\/strong><\/td><\/tr><tr><td>Motilal Oswal<\/td><td>BUY<\/td><td>Q4 recovery potential; sector tailwinds intact<\/td><\/tr><tr><td>YES Securities<\/td><td>ADD<\/td><td>Earnings inflection expected; watch Q4 guidance<\/td><\/tr><tr><td>Kotak Institutional<\/td><td>NEUTRAL<\/td><td>Fair valued at current levels; execution key<\/td><\/tr><\/tbody><\/table><\/figure><h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Conclusion\"><\/span><strong>Conclusion<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2><p>Gaudium IVF and Women Health Q4 FY26 results on May 15, 2026 will be the most important quarterly event of FY26. At Rs 185 \u2014 down -37% from its 52-week high of Rs 298 \u2014 the stock enters results season having already priced in significant headwinds. Revenue above Rs 185 Cr with EBITDA 16% would constitute a beat relative to current analyst consensus. Management&#8217;s FY27 guidance on 18% IVF cycles YoY trajectory will be the primary re-rating catalyst.<\/p><p><strong>Disclaimer: <\/strong>Investment in the share market is subject to risk. This article is for informational and educational purposes only and does not constitute investment advice. All financial data and analyst estimates are sourced from publicly available information. Verify all numbers before investing. Consult a SEBI-registered financial advisor before making investment decisions.<\/p><p>For more Q4 FY26 results previews, visit <a href=\"https:\/\/univest.in\/blogs\">Univest Blogs<\/a>.<\/p><h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Frequently_Asked_Questions\"><\/span><strong>Frequently Asked Questions<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2><h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Q_When_is_Gaudium_IVF_and_Women_Health_Q4_results_2026_date\"><\/span><strong>Q: When is Gaudium IVF and Women Health Q4 results 2026 date?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3><p>Gaudium IVF and Women Health Q4 FY26 results date is May 15, 2026. The board will approve the quarter and full-year FY26 financial results, consider a final dividend, and provide FY27 guidance.<\/p><h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Q_What_is_Gaudium_IVF_and_Women_Health_Q4_FY26_revenue_estimate\"><\/span><strong>Q: What is Gaudium IVF and Women Health Q4 FY26 revenue estimate?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3><p>Analyst consensus estimate for Gaudium IVF and Women Health Q4 FY26 revenue is Rs 185 Cr. Q3 FY26 actual revenue was Rs 161 Cr. Actual Q4 results may differ based on operating conditions and management execution.<\/p><h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Q_What_is_Gaudium_IVF_and_Women_Health_Q4_FY26_PAT_estimate\"><\/span><strong>Q: What is Gaudium IVF and Women Health Q4 FY26 PAT estimate?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3><p>Analyst consensus estimate for Gaudium IVF and Women Health Q4 FY26 net profit (PAT) is Rs 14 Cr. Q3 FY26 actual PAT was Rs 12 Cr. Estimates are indicative and subject to quarterly variance.<\/p><h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Q_Will_Gaudium_IVF_and_Women_Health_declare_a_dividend_in_Q4_FY26\"><\/span><strong>Q: Will Gaudium IVF and Women Health declare a dividend in Q4 FY26?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3><p>Gaudium IVF and Women Health is expected to declare Rs 0 for FY26, subject to board approval at the May 15, 2026 meeting and subsequent shareholder approval at the AGM. Verify actual dividend announcement before making any investment decision.<\/p><h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Q_What_is_Gaudium_IVF_and_Women_Health_current_share_price\"><\/span><strong>Q: What is Gaudium IVF and Women Health current share price?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3><p>Gaudium IVF and Women Health is trading at Rs 185 as of April 2026 \u2014 down -37% from its 52-week high of Rs 298. The 52-week low is Rs 155. Track the live price on the Univest Screener.<\/p><h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Q_What_were_Gaudium_IVF_and_Women_Health_Q3_FY26_results\"><\/span><strong>Q: What were Gaudium IVF and Women Health Q3 FY26 results?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3><p>In Q3 FY26, Gaudium IVF and Women Health reported revenue of Rs 161 Cr and net profit (PAT) of Rs 12 Cr. Q4 FY26 results on May 15, 2026 will provide the full-year FY26 comparison.<\/p><h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Q_When_do_TCS_and_Infosys_announce_Q4_results_2026\"><\/span><strong>Q: When do TCS and Infosys announce Q4 results 2026?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3><p>TCS declared Q4 FY26 results on April 9, 2026. Infosys is scheduled for April 23, 2026. Both are covered in detail at univest.in\/blogs. Check the earnings calendar table above for other key result dates.<\/p><h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Q_Is_Gaudium_IVF_and_Women_Health_a_good_investment_ahead_of_Q4_results\"><\/span><strong>Q: Is Gaudium IVF and Women Health a good investment ahead of Q4 results?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3><p>This article does not constitute investment advice. Gaudium IVF and Women Health at Rs 185 trades -37% below its 52-week high of Rs 298. Analyst consensus estimates suggest Q4 FY26 revenue of Rs 185 Cr and PAT of Rs 14 Cr. Review the factors, risks, and analyst ratings above. Consult a SEBI-registered financial advisor before making any investment decision.<\/p><h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Recent_Article\"><\/span><strong>Recent Article<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2><p><a href=\"https:\/\/univest.in\/blogs\/balkrishna-industries-q4-results-2026\">Balkrishna Industries Q4 Results 2026: Date, Revenue, PAT &amp; Analyst Outlook<\/a><\/p><p><a href=\"https:\/\/univest.in\/blogs\/balkrishna-paper-mills-q4-results-2026\">Balkrishna Paper Mills Q4 Results 2026: Date, Revenue, PAT &amp; Analyst Outlook<\/a><\/p><p><a href=\"https:\/\/univest.in\/blogs\/balaxi-pharmaceuticals-q4-results-2026\">BALAXI PHARMACEUTICALS Q4 Results 2026: Date, Revenue, PAT &amp; Analyst Outlook<\/a><\/p><p><a href=\"https:\/\/univest.in\/blogs\/balaji-telefilms-q4-results-2026\">Balaji Telefilms Q4 Results 2026: Date, Revenue, PAT &amp; Analyst Outlook<\/a><\/p><p><a href=\"https:\/\/univest.in\/blogs\/balaji-amines-q4-results-2026\">Balaji Amines Q4 Results 2026: Date, Revenue, PAT &amp; Analyst Outlook<\/a><\/p>","protected":false},"excerpt":{"rendered":"<p>Gaudium IVF and Women Health (NSE: GAUDIUM) is scheduled to declare its Q4 FY26 results on May 15, 2026, when the board of directors will approve the audited financial statements for the January\u2013March 2026 quarter and the full year FY2025\u201326. The stock trades at Rs 185 as of April 2026 \u2014 down -37% from its<\/p>\n","protected":false},"author":27,"featured_media":72939,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[842],"tags":[3802,3862],"class_list":["post-72935","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news","tag-news","tag-q4-results-expectations"],"metadata":{"_edit_lock":["1776345963:27"],"_last_editor_used_jetpack":["block-editor"],"rank_math_internal_links_processed":["1"],"amazonS3_cache":["a:8:{s:63:\"\/\/univest.in\/blogs-2\/wp-content\/uploads\/2026\/04\/image-1012.jpeg\";a:2:{s:2:\"id\";i:72937;s:11:\"source_type\";s:13:\"media-library\";}s:72:\"\/\/univest.in\/blogs-2\/wp-content\/uploads\/2026\/04\/image-1012-1024x536.jpeg\";a:2:{s:2:\"id\";i:72937;s:11:\"source_type\";s:13:\"media-library\";}s:95:\"\/\/univest-blog.storage.googleapis.com\/blogs\/wp-content\/uploads\/2026\/04\/16185227\/image-1012.jpeg\";a:2:{s:2:\"id\";i:72937;s:11:\"source_type\";s:13:\"media-library\";}s:104:\"\/\/univest-blog.storage.googleapis.com\/blogs\/wp-content\/uploads\/2026\/04\/16185227\/image-1012-1024x536.jpeg\";a:2:{s:2:\"id\";i:72937;s:11:\"source_type\";s:13:\"media-library\";}s:102:\"\/\/univest.in\/blogs-2\/wp-content\/uploads\/2026\/04\/Gaudium-IVF-and-Women-Health-Share-Price-Anlaysts-.jpg\";a:2:{s:2:\"id\";i:72941;s:11:\"source_type\";s:13:\"media-library\";}s:111:\"\/\/univest.in\/blogs-2\/wp-content\/uploads\/2026\/04\/Gaudium-IVF-and-Women-Health-Share-Price-Anlaysts--1024x536.jpg\";a:2:{s:2:\"id\";i:72941;s:11:\"source_type\";s:13:\"media-library\";}s:134:\"\/\/univest-blog.storage.googleapis.com\/blogs\/wp-content\/uploads\/2026\/04\/16185452\/Gaudium-IVF-and-Women-Health-Share-Price-Anlaysts-.jpg\";a:2:{s:2:\"id\";i:72941;s:11:\"source_type\";s:13:\"media-library\";}s:143:\"\/\/univest-blog.storage.googleapis.com\/blogs\/wp-content\/uploads\/2026\/04\/16185452\/Gaudium-IVF-and-Women-Health-Share-Price-Anlaysts--1024x536.jpg\";a:2:{s:2:\"id\";i:72941;s:11:\"source_type\";s:13:\"media-library\";}}"],"rank_math_seo_score":["82"],"rank_math_robots":["a:2:{i:0;s:7:\"noindex\";i:1;s:8:\"nofollow\";}"],"rank_math_title":["Gaudium IVF and Women Health Q4 Results 2026: Date, Revenue, PAT &amp; Analyst Outlook"],"rank_math_description":[" Gaudium IVF and Women Health Q4 FY26 results date is May 15, 2026. Revenue estimate Rs 185 Cr, PAT estimate Rs 14 Cr. Key factors, risks, analyst ratings and share price outlook for 2026.\n"],"rank_math_focus_keyword":["Gaudium IVF and Women Health"],"rank_math_primary_category":["842"],"_thumbnail_id":["72939"],"_edit_last":["27"],"_ez-toc-disabled":[""],"_ez-toc-insert":[""],"_ez-toc-header-label":[""],"_ez-toc-alignment":["none"],"_ez-toc-heading-levels":["a:0:{}"],"_ez-toc-alttext":[""],"_ez-toc-visibility_hide_by_default":[""],"_ez-toc-hide_counter":[""],"_ez-toc-exclude":[""],"_ez-toc-position-specific":["before"],"stm_select_gm_zoom":[""],"stm_agenda":[""],"stm_host":[""],"stm_select_approved_denied":[""],"stm_multiselect_approved":[""],"stm_multiselect_denied":[""],"stm_date":[""],"stm_time":[""],"stm_timezone":[""],"stm_duration":[""],"stm_password":[""],"stm_waiting_room":[""],"stm_join_before_host":[""],"stm_host_join_start":[""],"stm_start_after_participants":[""],"stm_mute_participants":[""],"stm_enforce_login":[""],"stm_alternative_hosts":[""],"top_bar_custom_style":[""],"top_bar_bg":[""],"wc_top_bar_cart_custom_style":[""],"wc_top_bar_cart_color":[""],"wc_top_bar_cart_icon_color_hover":[""],"wc_top_bar_cart_counter_color":[""],"wc_top_bar_cart_counter_color_hover":[""],"wc_top_bar_cart_counter_bg":[""],"wc_top_bar_cart_counter_bg_hover":[""],"top_bar_wpml_switcher_custom_style":[""],"wpml_switcher_color":[""],"top_bar_wpml_switcher_bg":[""],"top_bar_wpml_switcher_bg_hover":[""],"top_bar_wpml_switcher_color_hover":[""],"top_bar_socials_custom_style":[""],"top_bar_socials_color":[""],"top_bar_socials_color_hover":[""],"top_bar_search_custom_style":[""],"top_bar_search_color":[""],"top_bar_search_icon_color_hover":[""],"top_bar_contact_info_style":[""],"top_bar_contact_info_color":[""],"top_bar_contact_info_link_color":[""],"top_bar_contact_info_link_color_hover":[""],"top_bar_contact_info_select_bg":[""],"top_bar_contact_info_select_color":[""],"top_bar_contact_info_select_drop_bg":[""],"top_bar_contact_info_select_items_bg":[""],"top_bar_contact_info_select_items_color":[""],"top_bar_contact_info_select_items_hover":[""],"header_inverse":["default"],"enable_header_transparent":["off"],"header_nav_custom_style":[""],"header_bg":[""],"header_shadow":[""],"wc_cart_custom_style":[""],"wc_cart_icon_color":[""],"wc_cart_icon_color_hover":[""],"wc_cart_counter_color":[""],"wc_cart_counter_color_hover":[""],"wc_cart_counter_bg":[""],"wc_cart_counter_bg_hover":[""],"header_wpml_switcher_custom_style":[""],"header_wpml_switcher_color":[""],"header_wpml_switcher_color_hover":[""],"header_wpml_switcher_bg":[""],"header_wpml_switcher_bg_hover":[""],"header_socials_custom_style":[""],"header_socials_color":[""],"header_socials_color_hover":[""],"header_search_custom_style":[""],"header_search_icon_color":[""],"header_search_icon_color_hover":[""],"header_contact_info_style":[""],"header_contact_info_color":[""],"header_contact_info_link_color":[""],"header_contact_info_link_color_hover":[""],"header_button_custom_style":[""],"header_button_color":[""],"header_button_color_hover":[""],"header_button_bg":[""],"header_button_bg_hover":[""],"header_nav_menu_customize":[""],"header_nav_menu_link_color":[""],"header_nav_menu_link_color_hover":[""],"header_nav_menu_link_color_active":[""],"header_nav_menu_link_arrow_color":[""],"header_nav_menu_link_arrow_color_hover":[""],"header_nav_menu_level_1_bg":[""],"header_nav_menu_level_1_link_color":[""],"header_nav_menu_level_1_link_color_hover":[""],"header_nav_menu_level_1_link_bg_hover":[""],"header_nav_menu_level_1_link_arrow_color":[""],"header_nav_menu_level_1_link_arrow_color_hover":[""],"header_nav_menu_level_2_bg":[""],"header_nav_menu_level_2_link_color":[""],"header_nav_menu_level_2_link_color_hover":[""],"header_nav_menu_level_2_link_bg_hover":[""],"header_mega_menu_bg":[""],"header_mega_menu_title_color":[""],"header_mega_menu_title_color_hover":[""],"header_mega_menu_description_color":[""],"header_mega_menu_description_link_color":[""],"header_mega_menu_description_link_color_hover":[""],"header_mega_menu_color":[""],"header_mega_menu_color_hover":[""],"header_mega_menu_border_color":[""],"header_mega_menu_icons_color":[""],"header_nav_menu_customize_end":[""],"hfe_enabled_notice":[""],"disable_title_box":["default"],"hfe_disabled":[""],"enable_transparent":["default"],"title_box_title_bg_color":[""],"title_box_bg_custom_image":["default"],"title_box_bg_image":[""],"title_box_bg_position":["default"],"metabox_title_box_bg_position_x":[""],"metabox_title_box_bg_position_y":[""],"metabox_title_box_bg_attachment":["default"],"title_box_bg_size":["default"],"metabox_title_box_bg_size_slider":[""],"title_box_bg_repeat":["default"],"disable_title":["default"],"title_box_title_color":[""],"title_box_title_line_color":[""],"disable_breadcrumbs":["default"],"metabox_title_box_breadcrumbs_color":[""],"metabox_title_box_links_color":[""],"metabox_title_box_links_color_hover":[""],"content_bg_transparent":[""],"show_popup_single":[""],"popups_single":[""],"popups_single_event":[""],"popup_single_event_open_delay":[""],"popup_single_event_showing_in":[""],"popup_single_event_date_from":[""],"popup_single_event_date_to":[""],"popup_single_event_time_from":[""],"popup_single_event_time_to":[""],"popup_single_animation":[""],"popup_single_responsive":[""],"separator_footer_copyright_border_t":[""],"name":[""],"email":[""],"phone":[""],"company":[""],"memberId":[""],"testimonial_position":[""],"testimonial_company":[""],"testimonial_bg_img":[""],"testimonial_video_url":[""],"popups_width":[""],"popups_height":[""],"popups_image_bg":[""],"popups_color_bg":[""],"popups_border_radius":[""],"popups_template":[""],"rank_math_analytic_object_id":["8336"]},"jetpack_sharing_enabled":true,"jetpack_featured_media_url":"https:\/\/univest-blog.storage.googleapis.com\/blogs\/wp-content\/uploads\/2026\/04\/16185355\/Gaudium-IVF-and-Women-Health-Q4-FY26-Preview.jpg","_links":{"self":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/72935","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/users\/27"}],"replies":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/comments?post=72935"}],"version-history":[{"count":1,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/72935\/revisions"}],"predecessor-version":[{"id":72943,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/72935\/revisions\/72943"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media\/72939"}],"wp:attachment":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media?parent=72935"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/categories?post=72935"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/tags?post=72935"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}